|
Title |
|
|
|
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
| |
Author |
|
|
|
| |
Abstract |
|
|
| | |
Language |
|
|
|
English
| |
Source (journal) |
|
|
|
Nature communications | |
Publication |
|
|
|
2018
| |
ISSN |
|
|
|
2041-1723
| |
Volume/pages |
|
|
|
9(2018), 16 p.
| |
Article Reference |
|
|
|
4112
| |
ISI |
|
|
|
000446496100003
| |
Pubmed ID |
|
|
|
30291241
| |
Medium |
|
|
|
E-only publicatie
| |
Full text (Publisher's DOI) |
|
|
| | |
Full text (open access) |
|
|
| | |
|
Faculty/Department |
|
|
| | |
Research group |
|
|
|
Project info |
|
|
|
ANGIOPREDICT: Predictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer
Publication type |
|
|
| | | |
Subject |
|
|
| | | |
Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
Identification |
|
| |
|
|
Creation |
|
| |
09.11.2018
|
|
Last edited |
|
| |
16.04.2021
|
|
To cite this reference |
|
|
| | |
|
| |